drugset / Trial / NCT03543826

Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex

NCT03543826

Phase 4 Completed 201 enrolled University of Washington
NaSingle-groupOpen-labelPrevention

Summary

This is an estimation study, prospectively evaluating the incidence of postoperative residual neuromuscular blockade (PRNB) when a best practice protocol is implemented for a cohort of abdominal surgery and orthopedic surgery patients. The protocol is developed within the constraint of subjective monitoring, quantitative monitoring is not used, and use of rocuronium for paralysis and either neostigmine or sugammadex for reversal. The primary outcome is the incidence of PRNB on arrival to the post-anesthesia care unit, defined as a train-of-four ration \<0.9.

Timeline

Start
2018-05-21
Primary completion
2018-11-26
Completion
2018-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified
Subject Rocuronium Other / unclassified
Subject Sugammadex Other / unclassified

Indications